BIO-TECHNE Corp (NASDAQ:TECH)
Insiders here have filed 20 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Keeps a healthy share of every dollar it sells.
- Revenue
- $1.22B
- Net income
- $181.9M
- Net margin
- 15.0%
Little or no net debt.
- Total debt
- $289.1M
- Cash
- $264.7M
- Net debt / EBITDA
- 0.07x
Comfortably covers what is due within a year.
- Current assets
- $744.4M
- Current liabilities
- $163.7M
- Current ratio
- 4.55
The business funds itself from operations.
- Operating cash flow
- $292.1M
- Free cash flow
- $263.2M
- FCF margin
- 21.7%
Not funding itself by issuing shares.
- Shares outstanding
- 156.0M
- Share growth (1y)
- 0.7%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
TECH Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 321.19 M | 311.42 M | 295.88 M | 286.56 M | 316.96 M | 316.18 M |
| Revenue Growth (YoY) | 1.33 % | -1.51 % | -0.39 % | -1.00 % | 3.55 % | 4.20 % |
| Cost of Revenue | 109.80 M | 103.13 M | 104.60 M | 98.44 M | 118.15 M | 101.63 M |
| Gross Profit | 211.39 M | 208.29 M | 191.28 M | 188.11 M | 198.81 M | 214.56 M |
| SG&A Expense | 113.17 M | 109.34 M | 113.69 M | 116.21 M | 23.22 M | 151.27 M |
| R&D Expense | 23.95 M | 23.45 M | 23.13 M | 24.24 M | 26.03 M | 24.58 M |
| Operating Expenses | 137.12 M | 132.79 M | 136.82 M | 140.45 M | 222.67 M | 175.85 M |
| Operating Income | 74.28 M | 75.50 M | 54.46 M | 47.66 M | -23.86 M | 38.71 M |
| Pretax Income | 70.68 M | 71.22 M | 50.78 M | 47.99 M | -22.86 M | 38.27 M |
| Tax Provision | 16.06 M | 20.18 M | 12.78 M | 9.81 M | -5.18 M | 15.69 M |
| Net Income | 54.61 M | 51.06 M | 38.01 M | 38.19 M | -17.68 M | 22.59 M |
| EPS (Basic) | 0.35 | 0.33 | 0.24 | 0.25 | -0.11 | 0.14 |
| EPS (Diluted) | 0.36 | 0.32 | 0.24 | 0.24 | -0.11 | 0.14 |
| Shares Outstanding | 155.96 M | 155.89 M | 155.84 M | 155.46 M | 154.91 M | 157.37 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.